1,732 product recalls found in this category. Browse through all safety alerts and stay informed.
High Activity Category
This category has a significant number of recalls. Please check regularly for updates.
Zydus Pharmaceuticals recalled Chlorpromazine Hydrochloride Tablets on September 3, 2025. The recall affects 25 mg tablets due to high levels of N-Nitroso Desmethyl Chlorpromazine. Consumers must stop using the product immediately.
Zydus Pharmaceuticals recalled Chlorpromazine Hydrochloride Tablets on September 3, 2025. The recall affects a specific lot due to contamination with N-Nitroso Desmethyl Chlorpromazine. Consumers should stop using the product immediately and seek guidance from healthcare providers.
Philips Medical Systems Netherlands B.V. recalled 1,117 X-ray imaging systems on September 3, 2025. The recall affects product codes 722010, 722026, and 722003 due to potential internal component deterioration. This issue may render motorized movements inoperable, posing a risk to patient care.
Zydus Pharmaceuticals recalled Chlorpromazine Hydrochloride Tablets on September 3, 2025. The tablets exceed the acceptable limit for N-Nitroso Desmethyl Chlorpromazine. This recall affects the nationwide distribution in the USA.
Philips Medical Systems Nederland B.V. recalled the Allura Xper FD20/15 OR Table on September 3, 2025. The recall affects one unit distributed worldwide, including the U.S. Systems may not perform as intended due to internal component deterioration.
Philips Medical Systems recalled 2,114 Allura Xper FD20 imaging systems on September 3, 2025. The systems may fail due to internal component deterioration, risking loss of motorized functionality. This recall affects 791 units in the U.S. and 1,323 globally.
Philips Medical Systems Nederland B.V. recalled 75 Allura Xper FD20/20 imaging systems on September 3, 2025. The recall affects systems due to internal component deterioration, which can hinder motorized movements. All users must stop using the device immediately and follow manufacturer instructions for safe handling.
Philips Medical Systems Nederland B.V. recalled two operating room tables on September 3, 2025. The recall affects models 722022 and 722033 due to potential system failures. The malfunction can inhibit motorized movements, posing a risk to patients and healthcare providers.
Zydus Pharmaceuticals recalled Chlorpromazine Hydrochloride tablets on September 3, 2025. The recall affects tablets manufactured in India with high levels of a hazardous chemical. Consumers must stop using the product immediately and contact their healthcare provider.
Philips Medical Systems Netherlands B.V. recalled three Allura Xper FD20/20 OR Tables on September 3, 2025. The recall addresses potential failures in internal components that could impede motorized functions. Users must stop using the device immediately and follow recall instructions.
Zydus Lifesciences Ltd. recalled Chlorpromazine Hydrochloride Tablets on September 3, 2025. The recall affects tablets containing N-Nitroso Desmethyl Chlorpromazine above safe limits. Consumers should stop using the product immediately and consult healthcare providers.
Philips Medical Systems recalled 286 Allura Xper FD10/10 imaging systems on September 3, 2025. The recall affects models 722011, 722027, and 722005 due to potential failure of internal components. This malfunction could inhibit motorized movements, posing risks to patient safety.
Zydus Lifesciences Ltd. recalled Chlorpromazine Hydrochloride Tablets on September 3, 2025. The recall affects products with NDC 16714-050-01 due to high levels of a chemical impurity. Consumers should stop using the tablets immediately and contact healthcare providers.
Zydus Lifesciences recalled Chlorpromazine Hydrochloride Tablets on September 3, 2025. The tablets contain N-Nitroso Desmethyl Chlorpromazine above safe intake levels. Consumers must stop using the product immediately and consult healthcare providers.
Zydus Lifesciences recalled Chlorpromazine Hydrochloride Tablets on September 3, 2025. The recall affects tablets with NDC 16714-051-01 due to N-Nitroso Desmethyl Chlorpromazine exceeding acceptable limits. Consumers should stop using the product immediately and consult healthcare providers.
Philips Medical Systems Nederland B.V. recalled 45 Allura Xper FD20/10 imaging systems on September 3, 2025. The systems may fail due to internal component deterioration, posing a high risk to users. Affected units include 11 in the U.S. and 34 internationally.
Philips Medical Systems Nederland B.V. recalled 46 imaging systems on September 3, 2025. Deterioration of internal components may lead to loss of motorized movements. Healthcare providers must stop using the systems immediately and follow recall instructions.
Sun Pharmaceutical Industries recalled 1,870 kits of Technetium Tc 99m Mertiatide on September 3, 2025. The recall follows failed dissolution specifications for a key ingredient. The affected kits were distributed nationwide and pose a high risk to patients.
Philips Medical Systems Nederland B.V. recalled 174 OR tables on September 3, 2025. The recall affects models 722023, 722035, and 722015 due to potential failure of motorized movements. Users must stop using these devices immediately to prevent operational issues.
Philips Medical Systems Nederland B.V. recalled 268 Allura Xper FD20 Biplane systems on September 3, 2025. The recall affects units distributed globally due to potential failures in internal components. If malfunction occurs, motorized movements will be disabled, posing risks to operational efficiency.